Novavax Inc (XSWX:NVAX)
CHF 6.64 -0.090 (-1.34%) Market Cap: 1.09 Bil Enterprise Value: 691.72 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 49/100

Novavax Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 07:30 PM GMT
Release Date Price: CHF7.5 (-3.23%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NVAX.OQ - Novavax Inc
Novavax Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 07:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Well, good afternoon and welcome back to TD Callum's 46th annual healthcare conference. We're delighted today to be hosting Novavax and joining me from the company is CEO, John Jacobs, CFO Jim Kelly, and head of R&D Roxanderraglia.

So John, maybe to kick off Q&A. The company is successfully, executing its growth strategy, but maybe for investors that are less familiar with that, can you provide a high-level overview? Of what the company is doing.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah, thank you, Chris. In the last 3 years we've executed a successful pivot
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot